Markets:

Overview

News

Currencies

International

Treasuries

Acasti Pharma, Inc. - Common Stock (NQ:ACST)

3.370 UNCHANGED

Last Price Updated: 3:44 PM EDT, Oct 25, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Acasti Pharma, Inc. - Common Stock

< Previous 1 2 3 Next >

Stocks That Hit 52-Week Lows On Monday ↗

November 14, 2022

Monday saw 33 companies set new 52-week lows.

Via Benzinga

Acasti Pharma Reports Second Quarter 2023 Operational Results

November 14, 2022

From Acasti Pharma, Inc.

Via GlobeNewswire

Acasti Pharma to Present at Q4 Investor Summit

November 09, 2022

From Acasti Pharma, Inc.

Via GlobeNewswire

Recap: Acasti Pharma Q4 Earnings ↗

June 21, 2022

Acasti Pharma (NASDAQ:ACST) reported its Q4 earnings results on Tuesday, June 21, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Acasti Pharma's IV Hemorrhage Drug Candidate At Par With Oral Nimodipine ↗

May 18, 2022

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

November 11, 2022

On Friday, 63 stocks hit new 52-week lows.

Via Benzinga

Acasti Pharma to Report Second Quarter 2023 Financial Results on Monday, November 14, 2022

November 07, 2022

Call to be held on Monday, November 14th at 1:00 PM Eastern Time

From Acasti Pharma, Inc.

Via GlobeNewswire

Acasti Pharma Inc. (NASDAQ:ACST) (TSX.V:ACST) Featured in Coverage of Investor Summit Group’s Q4 Event

November 04, 2022

Via Investor Brand Network

Topics Intellectual Property

Acasti Announces Court Dismissal of Stockholder Litigation

September 30, 2022

From Acasti Pharma, Inc.

Via GlobeNewswire

121 Stocks That Hit Their 52-Week Low ↗

October 14, 2022

New Equities that Broke Through 52-Week Lows Friday Morning During Friday's morning session, 121 stocks hit new 52-week lows.

Via Benzinga

Acasti Announces Voting Results from 2022 Annual and Special Meeting of Shareholders

September 29, 2022

From Acasti Pharma, Inc.

Via GlobeNewswire

Acasti Pharma Inc. Discusses Clinical Progress of Lead Assets and 2022 Catalysts with The Stock Day Podcast

September 21, 2022

Phoenix, Arizona--(Newsfile Corp. - September 21, 2022) - The Stock Day Podcast welcomed Acasti Pharma Inc. (NASDAQ: ACST) ("the Company"),...

Via Newsfile

Acasti Pharma Announces Initiation of Pharmacokinetic Study for GTX-101, the Company’s Drug Candidate for the Treatment of Postherpetic Neuralgia

July 27, 2022

From Acasti Pharma, Inc.

Via GlobeNewswire

Acasti Pharma Inc. Discusses Year-End Results and Clinical Development Progress with The Stock Day Podcast

July 07, 2022

Phoenix, Arizona--(Newsfile Corp. - July 7, 2022) - The Stock Day Podcast welcomed Acasti Pharma Inc. (NASDAQ: ACST) ("the Company"),...

Via Newsfile

The Daily Biotech Pulse: Thumbs Down For Acadia's Pimavanserin, Pfizer Buys Stake In Valneva, AstraZeneca - Ionis Eplontersen Aces Rare Disease Trial ↗

June 21, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Earnings Scheduled For June 21, 2022 ↗

June 21, 2022

Companies Reporting Before The Bell • iHuman (NYSE:IH) is likely to report earnings for its first quarter.

Via Benzinga

The Daily Biotech Pulse: Pfizer/BioNTech's COVID-19 Booster For Kids, Moderna Starts First African Trial Of mRNA HIV Vaccine, Tonix Extends COVID-19 Antiviral Research Pact ↗

May 18, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours.

Via Benzinga

36 of the Best Ideas Companies to Present at the Spring into Action - Best Ideas Investor Conference on May 16th - 20th, 2022

May 16, 2022

RALEIGH, NC / ACCESSWIRE / May 16, 2022 / The Spring into Action- Best Ideas Virtual Investor Conference will take place on May 16th - 20th, 2022, where 36 SmallCap, MicroCap and NanoCap public...

From MicroCap Rodeo

Via AccessWire

Acasti Pharma CEO to Present at Microcap Rodeo's Spring into Action Best Ideas Virtual Conference on May 16th

May 12, 2022

LAVAL, QC / ACCESSWIRE / May 12, 2022 / Acasti Pharma Inc. ("Acasti" or the "Company") (NASDAQ:ACST)(TSXV:ACST), today announced that Jan D'Alvise, Chief Executive Officer, has been invited to present...

From Acasti Pharma Inc.

Via AccessWire

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

May 09, 2022

Good morning, trader! We're starting off another week of trading with an overview of the biggest pre-market stock mover for Monday!

Via InvestorPlace

20 Stocks Moving in Monday's Pre-Market Session ↗

May 09, 2022

Gainers Decisionpoint Systems, Inc. (NASDAQ: DPSI) shares rose 32.3% to $8.85 in pre-market trading after declining over 4% on Friday.

Via Benzinga

Acasti Pharma Inc. CEO, Jan D'Alvise, Is Featured on The Stock Day Podcast

February 22, 2022

Phoenix, Arizona--(Newsfile Corp. - February 22, 2022) - The Stock Day Podcast welcomed Acasti Pharma Inc. (NASDAQ: ACST) ("the Company"),...

Via Newsfile

Acasti Pharma's Earnings Outlook ↗

February 11, 2022

Acasti Pharma (NASDAQ:ACST) is set to give its latest quarterly earnings report on Monday, 2022-02-14. Here's what investors need to know before the announcement. Analysts estimate that Acasti Pharma...

Via Benzinga

Acasti Pharma: Bouncing Back With a New Drug Pipeline ↗

January 04, 2022

Picture credit: Louis Reed on Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial...

Via Benzinga

38 Stocks Moving In Thursday's Mid-Day Session ↗

December 23, 2021

Gainers Pasithea Therapeutics Corp. (NASDAQ: KTTA) jumped 37.3% to $2.0182. Pasithea recently said it expanded its footprint with second Ketamine Therapy Clinic in the UK....

Via Benzinga

Earnings Scheduled For February 14, 2022 ↗

February 14, 2022

Companies Reporting Before The Bell • Weber (NYSE:WEBR) is projected to report quarterly loss at $0.06 per share on revenue of $310.78 million.

Via Benzinga

BLITF Stock: 7 Thing to Know About Mobile Gaming Play i3 Interactive as Shares Rocket Today ↗

December 23, 2021

i3 Interactive (BLITF) stock is rising higher on heavy trading Thursday despite a lack of news from the mobile gambling company.

Via InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

December 23, 2021

Good morning, trader! Christmas is almost here but were aren't slowing down as we dive into the biggest pre-market stock movers for Thursday!

Via InvestorPlace

54 Biggest Movers From Thursday ↗

December 27, 2021

Gainers 22nd Century Group, Inc. (NASDAQ: XXII) surged 38.6% to settle at $3.05. The FDA authorized marketing of tobacco products that help reduce exposure to and consumption of...

Via Benzinga

18 Stocks Moving in Thursday's Pre-Market Session ↗

December 23, 2021

Gainers Pasithea Therapeutics Corp. (NASDAQ: KTTA) rose 26.5% to $1.86 in pre-market trading. Pasithea recently said it expanded its footprint with second Ketamine Therapy Clinic...

Via Benzinga

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.